Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Destache

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|November 9, 2016
An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV InfectionSubhra Mandal, Michael Belshan, Ashley Holec, et al.
Journal of Nanotechnology and Materials Science|June 9, 2018
Nanoparticle Encapsulation for Antiretroviral Pre-Exposure ProphylaxisKarl Khandalavala, Subhra Mandal, Rachel Pham, et al.
Current HIV Research|November 23, 2017
Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV TherapeuticsAshley D Holec, Subhra Mandal, Pavan Kumar Prathipati, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2021
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure ProphylaxisSubhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, et al.
Pharmaceutical Research|May 22, 2019
Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Pharmaceutical Research|September 15, 2017
Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Proceedings (Baylor University. Medical Center)|June 25, 2025
Cost analysis of urine testing for hospitalized patients in the emergency departmentA Corey Yeates, Jennifer A Zimmerman, Christopher J Destache, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2010
Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in miceChristopher J Destache, Todd Belgum, Michael Goede, et al.
BMC Infectious Diseases|December 17, 2009
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1Christopher J Destache, Todd Belgum, Keith Christensen, et al.
Antiviral Research|June 10, 2018
Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model studySubhra Mandal, Guobin Kang, Pavan Kumar Prathipati, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|November 9, 2016
An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV InfectionSubhra Mandal, Michael Belshan, Ashley Holec, et al.
Journal of Nanotechnology and Materials Science|June 9, 2018
Nanoparticle Encapsulation for Antiretroviral Pre-Exposure ProphylaxisKarl Khandalavala, Subhra Mandal, Rachel Pham, et al.
Current HIV Research|November 23, 2017
Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV TherapeuticsAshley D Holec, Subhra Mandal, Pavan Kumar Prathipati, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2021
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure ProphylaxisSubhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, et al.
Pharmaceutical Research|May 22, 2019
Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Pharmaceutical Research|September 15, 2017
Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Proceedings (Baylor University. Medical Center)|June 25, 2025
Cost analysis of urine testing for hospitalized patients in the emergency departmentA Corey Yeates, Jennifer A Zimmerman, Christopher J Destache, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2010
Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in miceChristopher J Destache, Todd Belgum, Michael Goede, et al.
BMC Infectious Diseases|December 17, 2009
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1Christopher J Destache, Todd Belgum, Keith Christensen, et al.
Antiviral Research|June 10, 2018
Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model studySubhra Mandal, Guobin Kang, Pavan Kumar Prathipati, et al.
Pageof 7